Should Immunosuppressive Therapy Be Modified During a Pandemic?

Marc A. Bouffard; Michael Levy; Andrew G. Lee; Gregory P. Van Stavern

doi:10.1097/WNO.0000000000001274

Should Immunosuppressive Therapy Be Modified During a Pandemic?

Marc A. Bouffard, Michael Levy, Andrew G. Lee, Gregory P. Van Stavern

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	266-271
Number of pages	6
Journal	Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Volume	41
Issue number	2
DOIs	https://doi.org/10.1097/WNO.0000000000001274
State	Published - Jun 1 2021

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1097/WNO.0000000000001274

Cite this

@article{6151b603cd7e4f6d843c6ec5b302e115,

title = "Should Immunosuppressive Therapy Be Modified During a Pandemic?",

author = "Bouffard, {Marc A.} and Michael Levy and Lee, {Andrew G.} and {Van Stavern}, {Gregory P.}",

year = "2021",

month = jun,

day = "1",

doi = "10.1097/WNO.0000000000001274",

language = "English (US)",

volume = "41",

pages = "266--271",

journal = "Journal of Neuro-Ophthalmology",

issn = "1070-8022",